Vaccine Adjuvants Market Reports 2018-2025: Novavax, Zhuoyue, Aphios, GSK, SPI Pharma, Novavax
The worldwide market for Vaccine Adjuvants is expected to grow at a CAGR of roughly 10.3% over the next five years, will reach 1010 million US$ in 2023, from 560 million US$ in 2017, according to a new Marketexpertz Study.
View full press release